CDKN2A and coronary artery disorder: In fact, when allelic expression control through 3D-enhancer looping was specifically measured in a separate study in human coronary aortic SMCs (64), physical contacts of CAD variant-containing enhancers in the locus and the promoters of CDKN2A, CDKN2B, and ANRIL were corroborated.